ISOLATION OF GENE FOR X-LINKED LYMPHOPROLIFERATION
ISOLATION OF GENE FOR X-LINKED LYMPHOPROLIFERATION
批准号:
2390837
负责人:
Daniel A. Haber
金额:
$25.4万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-01 至 1999-03-31
关键词:
Callithricidae Epstein Barr virus artificial chromosomes cell growth regulation gene expression gene mutation genetic library genetic markers genetic models inborn immunodeficiency laboratory mouse lymphoma molecular cloning molecular genetics monoclonal antibody neoplasm /cancer genetics nucleic acid sequence polymerase chain reaction sex linked trait structural genes tissue /cell culture transfection /expression vector virus related neoplasm /cancer
中文摘要
x连锁淋巴增生性综合征(XLP)是一种遗传性疾病
英文摘要
X-linked lymphoproliferative syndrome (XLP) is an inherited
immunodeficiency specific to infection by Epstein-Barr virus (EBV). Rather
than self-limited infectious mononucleosis following primary exposure to
EBV, affected boys develop uncontrolled proliferation of EBV-transformed
B cells, often culminating in fatal lymphoma. XLP is therefore a genetic
model for the EBV-induced lymphomas seen in MDS patients and in organ
transplant recipients. The nature of the inherited defect in XLP patients
is unknown, and no consistent immunological abnormalities have been
demonstrated in these children prior to EBV infection. We propose
experiments aimed at isolating the XLP disease gene by a "positional
cloning" approach.
The XLP gene has been mapped to a genetic locus at chromosome Xq25, and
three unrelated patients with homozygous germline deletions of
approximately 2 megabases at that locus have been reported. Boys who are
homozygous for this large deletion on the X chromosome have no clinical
abnormalities other than XLP, suggesting that no other "critical" genes
are present within that chromosomal locus. We identified the first of
three known genomic markers within the common region deleted-in all three
XLP patients, and have used these as starting points in establishing a
yeast artificial chromosome (YAC) contig spanning the deletion. To
identify potential transcripts within this region, we are using Exon
Amplification, a highly sensitive technique developed to "trap" exons from
genomic DNA. Potential exons will be used to screen cDNA libraries and
will also be useful as markers in ordering the YAC contig. Candidate cDNAs
will be screened by sequencing, tissue distribution of expression, and
analysis for mutations in XLP patients who do not have gross chromosomal
deletions. The identification of the XLP disease gene will allow
biochemical and functional experiments aimed at defining its role in the
growth control of EBV-transformed lymphoid cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10673075
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
-
批准号:10544808
-
项目类别:
-
资助金额:$63.47万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10199185
-
项目类别:
-
资助金额:$45.23万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
-
批准号:10327299
-
项目类别:
-
资助金额:$63.19万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10455704
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
-
批准号:9924267
-
项目类别:
-
资助金额:$60.7万
-
财政年份:2018
-
负责人:Daniel A. Haber
-
依托单位:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
-
批准号:10429911
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2018
-
负责人:Daniel A. Haber
-
依托单位:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
-
批准号:10152522
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2018
-
负责人:Daniel A. Haber
-
依托单位:
P1 - Clinical Correlations of WTX Inactivation in Wilms Tumor
-
批准号:8079677
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Point-of care Microfluidics for Early Detection of Cancer
-
批准号:8999413
-
项目类别:
-
资助金额:$172.16万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Data Production, and Informatics and Integration
-
批准号:8125843
-
项目类别:
-
资助金额:$86.5万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Clinical Correlations of WTX Inactivation in Wilms Tumor
-
批准号:7742536
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2009
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7912612
-
项目类别:
-
资助金额:$35.04万
-
财政年份:2009
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:8019551
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling and Circumventing EMT to Suppress Metastasis
-
批准号:8502812
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:8215774
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling and Circumventing EMT to Suppress Metastasis
-
批准号:8826042
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells
-
批准号:10374103
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7780378
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7461079
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
海外基金